Robert J. Lee
Impact in
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 108
- Advanced biosensing and bioanalysis techniques 58
- DNA and Nucleic Acid Chemistry 15
- Biomaterials 60
- Nanoparticle-Based Drug Delivery 60
- Co-authors
- Lesheng Teng (56 shared papers)Xinwei Cheng (10 shared papers)Wenjin Guo (7 shared papers)Bo Yu (14 shared papers)Jing Xie (28 shared papers)Josimar O. Eloy (10 shared papers)Zhaogang Yang (11 shared papers)Raquel Petrilli (9 shared papers)
- Journals
- International Journal of Pharmaceutics (23 papers)Molecular Pharmaceutics (13 papers)Blood (9 papers)Nanomedicine Nanotechnology Biology and Medicine (9 papers)Pharmaceutical Research (8 papers)
- Partner nations
- United StatesChinaBrazil
In The Last Decade
Robert J. Lee
265 papers receiving 13.4k citations
Robert J. Lee's Hit Papers
Peers
Comparison fields: 5 of 172
- Biomaterials 3.7k
- Pharmaceutical Science 1.1k
- Molecular Biology 6.9k
- Molecular Medicine 439
- Cancer Research 1.1k
Countries citing papers authored by Robert J. Lee
This map shows the geographic impact of Robert J. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Lee more than expected).
Fields of papers citing papers by Robert J. Lee
This network shows the impact of papers produced by Robert J. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Lee. The network helps show where Robert J. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert J. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 268 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery Hit paper breakdown → | 2016 | 536 |
| 2 | 2014 | 409 | |
| 3 | 2004 | 384 | |
| 4 | 2001 | 383 | |
| 5 | 2010 | 371 | |
| 6 | Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application Hit paper breakdown → | 2020 | 351 |
| 7 | 2017 | 318 | |
| 8 | 2010 | 295 | |
| 9 | 1996 | 215 | |
| 10 | 2012 | 197 | |
| 11 | 2016 | 179 | |
| 12 | 2006 | 173 | |
| 13 | 2002 | 168 | |
| 14 | Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. | 1996 | 162 |
| 15 | 2002 | 155 | |
| 16 | 2013 | 153 | |
| 17 | 1997 | 134 | |
| 18 | 2013 | 132 | |
| 19 | 2009 | 132 | |
| 20 | 2017 | 131 |
About Robert J. Lee
Robert J. Lee is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Immunology and Cancer Research, having authored 268 papers that have together received 13.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (108 papers), Nanoparticle-Based Drug Delivery (60 papers), Advanced biosensing and bioanalysis techniques (58 papers), MicroRNA in disease regulation (16 papers), Nanoplatforms for cancer theranostics (16 papers), DNA and Nucleic Acid Chemistry (15 papers), Immunotherapy and Immune Responses (10 papers) and Virus-based gene therapy research (10 papers). The work is most often cited by research in Biomaterials (3.7k citations), Pharmaceutical Science (1.1k citations), Molecular Biology (6.9k citations), Molecular Medicine (439 citations) and Cancer Research (1.1k citations). Robert J. Lee has collaborated with scholars based in United States, China and Brazil. Frequent co-authors include Lesheng Teng, Xinwei Cheng, Wenjin Guo, Bo Yu, Jing Xie, Josimar O. Eloy, Zhaogang Yang, Raquel Petrilli, Jun Wu and Philip S. Low. Their work appears in journals such as International Journal of Pharmaceutics, Molecular Pharmaceutics, Blood, Nanomedicine Nanotechnology Biology and Medicine and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.